In Alzheimer's disease (AD) and mild cognitive impairment, elevated VCAM‐1 levels have been associated with cognitive decline and hippocampal atrophy, and have even been incorporated into early blood biomarker panels [24, 25]. This evidence concerns the gene VCAM1 and hippocampal atrophy.